CLINICAL_TRIALS
research
· 2025-07-01
Clinical Trial Update: Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia
Summary
A University Hospital Basel study is evaluating urinary prostaglandin as a potential predictor for thiazide-induced hyponatremia and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Basel, Switzerland | Conditions: Thiazide-induced Hyponatremia (TIH) | Status: RECRUITING